These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20036131)

  • 1. Lobeline esters as novel ligands for neuronal nicotinic acetylcholine receptors and neurotransmitter transporters.
    Hojahmat M; Horton DB; Norrholm SD; Miller DK; Grinevich VP; Deaciuc AG; Dwoskin LP; Crooks PA
    Bioorg Med Chem; 2010 Jan; 18(2):640-9. PubMed ID: 20036131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters.
    Miller DK; Crooks PA; Zheng G; Grinevich VP; Norrholm SD; Dwoskin LP
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1035-45. PubMed ID: 15121762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defunctionalized lobeline analogues: structure-activity of novel ligands for the vesicular monoamine transporter.
    Zheng G; Dwoskin LP; Deaciuc AG; Norrholm SD; Crooks PA
    J Med Chem; 2005 Aug; 48(17):5551-60. PubMed ID: 16107155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Des-keto lobeline analogs with increased potency and selectivity at dopamine and serotonin transporters.
    Zheng G; Horton DB; Deaciuc AG; Dwoskin LP; Crooks PA
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5018-21. PubMed ID: 16905316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abuse.
    Crooks PA; Zheng G; Vartak AP; Culver JP; Zheng F; Horton DB; Dwoskin LP
    Curr Top Med Chem; 2011; 11(9):1103-27. PubMed ID: 21050177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release.
    Horton DB; Siripurapu KB; Norrholm SD; Culver JP; Hojahmat M; Beckmann JS; Harrod SB; Deaciuc AG; Bardo MT; Crooks PA; Dwoskin LP
    J Pharmacol Exp Ther; 2011 Mar; 336(3):940-51. PubMed ID: 21177475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lobelane inhibits methamphetamine-evoked dopamine release via inhibition of the vesicular monoamine transporter-2.
    Nickell JR; Krishnamurthy S; Norrholm S; Deaciuc G; Siripurapu KB; Zheng G; Crooks PA; Dwoskin LP
    J Pharmacol Exp Ther; 2010 Feb; 332(2):612-21. PubMed ID: 19855096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenyl ring-substituted lobelane analogs: inhibition of [³H]dopamine uptake at the vesicular monoamine transporter-2.
    Nickell JR; Zheng G; Deaciuc AG; Crooks PA; Dwoskin LP
    J Pharmacol Exp Ther; 2011 Mar; 336(3):724-33. PubMed ID: 20876747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Scaffold for Lead Compounds to Treat Methamphetamine Use Disorders.
    Lee NR; Zheng G; Crooks PA; Bardo MT; Dwoskin LP
    AAPS J; 2018 Feb; 20(2):29. PubMed ID: 29427069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse.
    Nickell JR; Siripurapu KB; Vartak A; Crooks PA; Dwoskin LP
    Adv Pharmacol; 2014; 69():71-106. PubMed ID: 24484975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. bis-Azaaromatic quaternary ammonium analogues: ligands for alpha4beta2* and alpha7* subtypes of neuronal nicotinic receptors.
    Ayers JT; Dwoskin LP; Deaciuc AG; Grinevich VP; Zhu J; Crooks PA
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3067-71. PubMed ID: 12372503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel N-1,2-dihydroxypropyl analogs of lobelane inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release.
    Horton DB; Siripurapu KB; Zheng G; Crooks PA; Dwoskin LP
    J Pharmacol Exp Ther; 2011 Oct; 339(1):286-97. PubMed ID: 21778282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of unsaturation into the N-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: effect on affinity and selectivity.
    Sumithran SP; Crooks PA; Xu R; Zhu J; Deaciuc AG; Wilkins LH; Dwoskin LP
    AAPS J; 2005 Aug; 7(1):E201-17. PubMed ID: 16146341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobeline inhibits nicotine-evoked [(3)H]dopamine overflow from rat striatal slices and nicotine-evoked (86)Rb(+) efflux from thalamic synaptosomes.
    Miller DK; Crooks PA; Dwoskin LP
    Neuropharmacology; 2000 Oct; 39(13):2654-62. PubMed ID: 11044735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of Novel Nicotinic Ligands with Multimodal Action: Targeting Acetylcholine α4β2, Dopamine and Serotonin Transporters.
    González-Gutiérrez JP; Pessoa-Mahana HA; Iturriaga-Vásquez PE; Reyes-Parada MI; Guerra-Díaz NE; Hodar-Salazar M; Viscarra F; Paillali P; Núñez-Vivanco G; Lorca-Carvajal MA; Mella-Raipán J; Zúñiga MC
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31652614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lobelane analogues containing 4-hydroxy and 4-(2-fluoroethoxy) aromatic substituents: Potent and selective inhibitors of [(3)H]dopamine uptake at the vesicular monoamine transporter-2.
    Joolakanti SR; Nickell JR; Janganati V; Zheng G; Dwoskin LP; Crooks PA
    Bioorg Med Chem Lett; 2016 May; 26(10):2422-2427. PubMed ID: 27080180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with alpha4beta2* and alpha7* neuronal nicotinic receptors.
    Wilkins LH; Grinevich VP; Ayers JT; Crooks PA; Dwoskin LP
    J Pharmacol Exp Ther; 2003 Jan; 304(1):400-10. PubMed ID: 12490617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.
    Carroll FI; Navarro HA; Mascarella SW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Jackson A; Damaj MI
    ACS Chem Neurosci; 2015 Jun; 6(6):920-6. PubMed ID: 25891987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lobeline displaces [3H]dihydrotetrabenazine binding and releases [3H]dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine.
    Teng L; Crooks PA; Dwoskin LP
    J Neurochem; 1998 Jul; 71(1):258-65. PubMed ID: 9648873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N, N -disubstituted piperazines and homopiperazines: synthesis and affinities at alpha4beta2* and alpha7* neuronal nicotinic acetylcholine receptors.
    Chen J; Deaciuc AG; Dwoskin LP; Crooks PA; Bai D
    J Enzyme Inhib Med Chem; 2006 Dec; 21(6):667-80. PubMed ID: 17252939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.